Lumeris

News

In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment stories from across the industry.

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.